{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:01:10Z","timestamp":1773716470693,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T00:00:00Z","timestamp":1352073600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048900","type":"journal-article","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T22:32:54Z","timestamp":1352154774000},"page":"e48900","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic"],"prefix":"10.1371","volume":"7","author":[{"given":"Claudia C.","family":"Dobler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy B.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement","volume":"161","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"SH Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"ref3","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","journal-title":"Bull World Health Organ"},{"key":"ref4","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"GW Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref5","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM (2000) Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev: CD001363."},{"key":"ref6","unstructured":"(2005) Charles P. Felton National Tuberculosis Center. Adherence to Treatment for Latent Tuberculosis Infection: A Manual for Health Care Providers. Link: http:\/\/cpmcnet.columbia.edu\/dept\/harlemtb\/Assets\/web_docs\/Harlem-LTBI%20Adherence6.pdf<\/ext-link>. Accessed 26th September 2012."},{"key":"ref7","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Y Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","article-title":"Predicting non-completion of treatment for latent tuberculous infection: a prospective survey","volume":"174","author":"FK Shieh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1378\/chest.122.5.1609","article-title":"Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital","volume":"122","author":"SJ Shukla","year":"2002","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"D Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","unstructured":"(2009) NSW Department of Health. Policy directive: Tuberculin Skin Testing. Link: http:\/\/www.health.nsw.gov.au\/policies\/pd\/2009\/pdf\/PD2009_005.pdf<\/ext-link>. Accessed 26th September 2012."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5694\/j.1326-5377.2011.tb03108.x","article-title":"Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory","volume":"194","author":"JM Trauer","year":"2011","journal-title":"Med J Aust"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"ref14","first-page":"701","article-title":"Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain","volume":"14","author":"L Anibarro","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","first-page":"703","article-title":"Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles","volume":"8","author":"A Coly","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00007611-200295040-00009","article-title":"Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States","volume":"95","author":"MR Reichler","year":"2002","journal-title":"South Med J"},{"key":"ref17","first-page":"775","article-title":"A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection","volume":"10","author":"AM Nyamathi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study","volume":"12","author":"ND Goswami","year":"2012","journal-title":"BMC Public Health"},{"key":"ref19","first-page":"1104","article-title":"Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience","volume":"14","author":"Y Hirsch-Moverman","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"KR Page","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"D Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","first-page":"208","article-title":"Acceptance of isoniazid preventive treatment by close contacts of tuberculosis cases: a 692-subject Italian study","volume":"2","author":"LR Codecasa","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/rmed.1999.0877","article-title":"Tuberculosis preventive therapy: perspective from a multi-ethnic community","volume":"94","author":"MS Sebastian","year":"2000","journal-title":"Respir Med"},{"key":"ref24","first-page":"218","article-title":"Tuberculosis treatment delivery in Bali: a qualitative study of clinic staff perceptions","volume":"8","author":"RE Watkins","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinf.2006.04.010","article-title":"Predictors of failure to complete treatment for latent tuberculosis infection","volume":"54","author":"AE Parsyan","year":"2007","journal-title":"J Infect"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1378\/chest.07-2024","article-title":"Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island","volume":"133","author":"A Kwara","year":"2008","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"CR Horsburgh Jr","year":"2010","journal-title":"Chest"},{"key":"ref28","first-page":"551","article-title":"Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment","volume":"14","author":"A Trajman","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref29","first-page":"1343","article-title":"In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection","volume":"9","author":"D Menzies","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.rmed.2010.02.001","article-title":"Point-of-care Arkansas method for measuring adherence to treatment with isoniazid","volume":"104","author":"RL Guerra","year":"2010","journal-title":"Respir Med"},{"key":"ref31","first-page":"1232","article-title":"Evaluation of the Arkansas method of urine testing for isoniazid in South Africa","volume":"11","author":"Y Hanifa","year":"2007","journal-title":"Int J Tuberc Lung Dis"}],"updated-by":[{"DOI":"10.1371\/annotation\/4498fd07-acae-49bb-abf2-d2e914a249d0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T00:00:00Z","timestamp":1386547200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T15:57:02Z","timestamp":1594828622000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048900"}},"subtitle":[],"editor":[{"given":"Miguel","family":"Santin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,5]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048900","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/4498fd07-acae-49bb-abf2-d2e914a249d0","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,5]]}}}